Senores Pharmaceuticals Acquires Apnar Pharma Along with Five ANDAs - geneonline.com
Yesterday • Google News
SENORES
NSEundefined 799.70.1%
Price Chart
Key Statistics
Market Cap
₹ 0
P/E Ratio
0.00
Revenue (TTM)
₹ 0
Volume
314.11K
52W High
₹ 0.00
52W Low
₹ 0.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
N/A
52 Week Low
N/A
About SENORES
No description available.
Employees
N/A
Headquarters
N/A
CEO
N/A
Latest News
Senores Pharmaceuticals to acquire Apnar Pharma, five ANDAs for Rs91 Cr - ETPharma.com
Yesterday • Google News
Senores Pharmaceuticals Acquires Apnar Pharma, Five ANDAs In Rs 91-Crore Deal - BW Healthcare
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg